Inhibitors | Comment | Organism | Structure |
---|---|---|---|
2-(2-(4-(6-bromo-3-(tert-butylamino)imidazo[1,2-a]pyridin-2-yl)phenoxy)propyl)isoindoline-1,3-dione | 34.28% inhibition at 0.05 mM | Homo sapiens | |
2-(3-(4-(3-(cyclohexylamino)-5-methylimidazo[1,2-a]pyridin-2-yl)phenoxy)propyl)isoindoline-1,3-dione | 87.94% inhibition at 0.05 mM | Homo sapiens | |
2-(3-(4-(3-(cyclohexylamino)-6-methylimidazo[1,2-a]pyridin-2-yl)phenoxy)propyl)isoindoline-1,3-dione | 63.7% inhibition at 0.05 mM | Homo sapiens | |
2-(3-(4-(3-(cyclohexylamino)-7-methylimidazo[1,2-a]pyridin-2-yl)phenoxy)propyl)isoindoline-1,3-dione | complete inhibition at 0.05 mM | Homo sapiens | |
2-(3-(4-(3-(cyclohexylamino)-8-methylimidazo[1,2-a]pyridin-2-yl)phenoxy)propyl)isoindoline-1,3-dione | 69.43% inhibition at 0.05 mM | Homo sapiens | |
2-(3-(4-(3-(cyclohexylamino)imidazo[1,2-a]pyridin-2-yl)-2-methoxyphenoxy)propyl)isoindoline-1,3-dione | 69.49% inhibition at 0.05 mM | Homo sapiens | |
2-(3-(4-(3-(cyclohexylamino)imidazo[1,2-a]pyridin-2-yl)phenoxy)propyl)isoindoline-1,3-dione | less than 10% inhibition at 0.05 mM | Homo sapiens | |
2-(3-(4-(3-(tert-butylamino)-6-chloroimidazo[1,2-a]pyridin-2-yl)-2-methoxyphenoxy)propyl)isoindoline-1,3-dione | 37.9% inhibition at 0.05 mM | Homo sapiens | |
2-(3-(4-(3-(tert-butylamino)-6-chloroimidazo[1,2-a]pyridin-2-yl)phenoxy)propyl)isoindoline-1,3-dione | 32.95% inhibition at 0.05 mM | Homo sapiens | |
2-(3-(4-(3-(tert-butylamino)-7-methylimidazo[1,2-a]pyridin-2-yl)phenoxy)propyl)isoindoline-1,3-dione | 24.24% inhibition at 0.01 mM | Homo sapiens | |
2-(3-(4-(6-bromo-3-(cyclohexylamino)imidazo[1,2-a]pyridin-2-yl)-2-methoxyphenoxy)propyl) isoindoline-1,3-dione | 43.17% inhibition at 0.05 mM | Homo sapiens | |
2-(3-(4-(6-bromo-3-(cyclohexylamino)imidazo[1,2-a]pyridin-2-yl)phenoxy)propyl)isoindoline-1,3-dione | 45.3% inhibition at 0.05 mM | Homo sapiens | |
2-(3-(4-(6-bromo-3-(tert-butylamino)imidazo[1,2-a]pyridin-2-yl)-2-methoxyphenoxy)propyl) isoindoline-1,3-dione | 48.72% inhibition at 0.05 mM | Homo sapiens | |
2-(3-(4-(6-chloro-3-(cyclohexylamino)imidazo[1,2-a]pyridin-2-yl)-2-methoxyphenoxy)propyl) isoindoline-1,3-dione | 88.097% inhibition at 0.05 mM | Homo sapiens | |
2-(3-(4-(6-chloro-3-(cyclohexylamino)imidazo[1,2-a]pyridin-2-yl)phenoxy)propyl)isoindoline-1,3-dione | 19.6% inhibition at 0.05 mM | Homo sapiens | |
OM99-2 | - |
Homo sapiens |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
amyloid-beta precursor protein + H2O | Homo sapiens | - |
? | - |
? |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | P56817 | - |
- |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
amyloid-beta precursor protein + H2O | - |
Homo sapiens | ? | - |
? | |
Rh-EVNLDAEFK-quencher + H2O | - |
Homo sapiens | ? | - |
? |
Synonyms | Comment | Organism |
---|---|---|
BACE1 | - |
Homo sapiens |
IC50 Value | IC50 Value Maximum | Comment | Organism | Inhibitor | Structure |
---|---|---|---|---|---|
0.000014 | - |
at pH 4.5 and 23°C | Homo sapiens | OM99-2 | |
0.00284 | - |
at pH 4.5 and 23°C | Homo sapiens | 2-(3-(4-(3-(cyclohexylamino)-7-methylimidazo[1,2-a]pyridin-2-yl)phenoxy)propyl)isoindoline-1,3-dione | |
0.00593 | - |
at pH 4.5 and 23°C | Homo sapiens | 2-(3-(4-(3-(cyclohexylamino)-5-methylimidazo[1,2-a]pyridin-2-yl)phenoxy)propyl)isoindoline-1,3-dione | |
0.0149 | - |
at pH 4.5 and 23°C | Homo sapiens | 2-(3-(4-(6-chloro-3-(cyclohexylamino)imidazo[1,2-a]pyridin-2-yl)-2-methoxyphenoxy)propyl) isoindoline-1,3-dione | |
0.02942 | - |
at pH 4.5 and 23°C | Homo sapiens | 2-(3-(4-(3-(cyclohexylamino)-6-methylimidazo[1,2-a]pyridin-2-yl)phenoxy)propyl)isoindoline-1,3-dione |